Phathom Pharmaceuticals, Inc. PHAT
6.28 USD +0.84 (+15.34%)
At closeNov 12, 2026, 4:25 AM EST
6.01 -0.27 -4.30%
Pre-market · Nov 12, 4:25 AM ET
5.41 Day range 6.32
5.02 52-week range 18.31
- YTD
- -62.15%
- 1 year
- -57.05%
PHAT revenue history
Revenue is income from the company’s ordinary business activities.
175,110,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 175,110,000 | 119,858,000 | 216.93% |
| FY 2024 | 2024-12-31 | 55,252,000 | 54,570,000 | 8001.47% |
| FY 2023 | 2023-12-31 | 682,000 | 682,000 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-01T06:01:14.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.